Leukemia Research Reports Oncology

T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemia

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →